@article{JTD16257,
author = {Vinicius Ernani and Apar Kishor Ganti},
title = {Surgery for limited-stage small cell lung cancer: ready for prime-time?},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {10},
year = {2017},
keywords = {},
abstract = {Small cell lung cancer (SCLC) represents approximately 13% of all newly diagnosed lung cancers in the United States (1). Around 40% of the patients present with limited-stage (LS) disease, and 60% with extensive-stage (ES) (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/16257}
}